Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

Pernot S, Terme M, Radosevic-Robin N, Castan F, Badoual C, Marcheteau E, Penault-Llorca F, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Baptiste Bachet J, Borg C, Boige V, Voron T, Stanbury T, Tartour E, Gourgou S, Malka D, Taieb J.

Gastric Cancer. 2019 Jul 2. doi: 10.1007/s10120-019-00983-3. [Epub ahead of print]

PMID:
31267360
2.

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis.

Outh-Gauer S, Augustin J, Mandavit M, Grard O, Denize T, Nervo M, Lépine C, Rassy M, Tartour E, Badoual C.

J Vis Exp. 2019 Jun 14;(148). doi: 10.3791/59422.

PMID:
31259898
3.

[An intriguing immunohistochemical expression profile for an adenosquamous carcinoma].

Lépine C, Kapfer J, El Ward Y, Badoual C.

Ann Pathol. 2019 Jun 25. pii: S0242-6498(19)30095-1. doi: 10.1016/j.annpat.2019.04.008. [Epub ahead of print] French. No abstract available.

PMID:
31253458
4.

The integrity of the FOG-2 LXCXE pRb-binding motif is required for small intestine homeostasis.

Goupille O, Kadri Z, Langelé A, Luccantoni S, Badoual C, Leboulch P, Chrétien S.

Exp Physiol. 2019 Jul;104(7):1074-1089. doi: 10.1113/EP087369. Epub 2019 May 14.

PMID:
31012180
5.

HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status.

Veyer D, Wack M, Grard O, Bonfils P, Hans S, Bélec L, Badoual C, Péré H.

Pathology. 2019 Jun;51(4):421-425. doi: 10.1016/j.pathol.2019.02.002. Epub 2019 Apr 17.

PMID:
31005250
6.

[Word of the patient: You, the anatomo-pathologists, you can help us understand and better fight our disease].

Badoual C.

Ann Pathol. 2019 Apr;39(2):75-76. doi: 10.1016/j.annpat.2019.03.001. French. No abstract available.

PMID:
30967193
7.

Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".

Péré H, Pavie J, Pernot S, Veyer D, Bertaud D, Hurel S, Bélec L, Hans S, Ménard M, Cochand-Priollet B, Weiss L, Bats AS, Badoual C; AP-HP CoMPap (Consultation Multidisciplinaire Papillomavirus) group.

Br J Cancer. 2019 Apr;120(9):952-953. doi: 10.1038/s41416-019-0439-0. Epub 2019 Mar 26. No abstract available.

PMID:
30911088
8.

[Augmented pathology, future or present ?]

Badoual C, Bibeau F.

Ann Pathol. 2019 Apr;39(2):71-72. doi: 10.1016/j.annpat.2019.02.009. Epub 2019 Mar 14. French. No abstract available.

PMID:
30879695
9.

[Diagnostic and treatment pitfalls and guidelines for variants of squamous cell carcinomas of the head and neck: on behalf of the REFCOR].

Thariat J, Hourseau M, Baglin AC, Digue L, Vulquin N, Badoual C, Baujat B, Janot F, Ferrand FR, Barry B.

Bull Cancer. 2019 Apr;106(4):395-403. doi: 10.1016/j.bulcan.2019.01.015. Epub 2019 Mar 13. French.

PMID:
30878134
10.

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M.

Cancers (Basel). 2019 Feb 27;11(3). pii: E283. doi: 10.3390/cancers11030283. Review.

11.

[Large scale teaching in pathology].

Bertheau P, Denize T, Calvani J, Gardair C, Jacquier A, Razafimahefa J, Eymerit-Morin C, Perron É, Tremblay-Le May R, Borduas M, Pote N, Battistella M, Badoual C, Fléjou JF, Leteurtre E, Uro-Coste E, Buob D, Valmary-Degano S.

Ann Pathol. 2019 Apr;39(2):144-150. doi: 10.1016/j.annpat.2018.12.009. Epub 2019 Jan 30. French.

PMID:
30711337
12.

Ten-year outcome of curative "exclusive" chemotherapy in N0M0 squamous cell carcinoma of the larynx and pharynx with complete clinical response.

Laccourreye O, Marret G, Rubin F, Fabre E, Badoual C, Oudard S, Bonfils P, Lisan Q.

Head Neck. 2019 Jul;41(7):2190-2196. doi: 10.1002/hed.25674. Epub 2019 Feb 1.

PMID:
30706570
13.

["In search of lost reviewers"].

Badoual C.

Ann Pathol. 2018 Dec;38(6):e1. doi: 10.1016/j.annpat.2018.10.005. French. No abstract available.

PMID:
30580806
14.

[Editorial].

Badoual C.

Ann Pathol. 2018 Oct;38(5):257. doi: 10.1016/j.annpat.2018.09.002. French. No abstract available.

PMID:
30309452
15.

IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract.

Tallegas M, Miquelestorena-Standley É, Labit-Bouvier C, Badoual C, Francois A, Gomez-Brouchet A, Aubert S, Collin C, Tallet A, de Pinieux G.

Hum Pathol. 2019 Feb;84:183-191. doi: 10.1016/j.humpath.2018.09.015. Epub 2018 Oct 5.

PMID:
30296521
16.

Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Kadlub N, Sessiecq Q, Mandavit M, L'Hermine AC, Badoual C, Galmiche L, Berdal A, Descroix V, Picard A, Coudert AE.

Orphanet J Rare Dis. 2018 Sep 20;13(1):166. doi: 10.1186/s13023-018-0907-2.

17.

[ENT benign lesions and pseudo-tumors: Case No. 7].

Badoual C.

Ann Pathol. 2018 Oct;38(5):293-298. doi: 10.1016/j.annpat.2018.08.002. Epub 2018 Sep 13. Review. French. No abstract available.

PMID:
30220544
18.

[ENT benign lesions and pseudo-tumors: Case no 8].

Badoual C.

Ann Pathol. 2018 Oct;38(5):299-304. doi: 10.1016/j.annpat.2018.08.001. Epub 2018 Sep 11. Review. French. No abstract available.

PMID:
30217402
19.

[Multidisciplinary consultation for patients with HPV-related invasive carcinoma or precancerous lesions].

Badoual C, Pavie J, Ménard M, Pernot S, Cochand-Priollet B, Hurel S, Péré H, Bats AS.

Cancer Radiother. 2018 Oct;22(6-7):487-491. doi: 10.1016/j.canrad.2018.07.137. Epub 2018 Sep 7. Review. French.

PMID:
30197024
20.

Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.

Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR, de Sanctis S, Schiavo-Lena M, Laco J, Badoual C, Santana Conceiçao T, Ptáková N, Baněčkova M, Miesbauerová M, Michal M.

Am J Surg Pathol. 2018 Nov;42(11):1445-1455. doi: 10.1097/PAS.0000000000001133.

PMID:
30045065
21.

HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population.

Augustin J, Mandavit M, Outh-Gauer S, Grard O, Gasne C, Lépine C, Mirghani H, Hans S, Bonfils P, Denize T, Bruneval P, Bishop JA, Fontugne J, Péré H, Tartour E, Badoual C.

Mod Pathol. 2018 Nov;31(11):1645-1652. doi: 10.1038/s41379-018-0090-y. Epub 2018 Jun 20.

PMID:
29925856
22.

[Rich and sad topics].

Badoual C.

Ann Pathol. 2018 Apr;38(2):69. doi: 10.1016/j.annpat.2018.03.003. French. No abstract available.

PMID:
29703419
23.

Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.

Augustin J, Outh-Gauer S, Mandavit M, Gasne C, Grard O, Denize T, Nervo M, Mirghani H, Laccourreye O, Bonfils P, Bruneval P, Veyer D, Péré H, Tartour E, Badoual C.

Hum Pathol. 2018 Aug;78:63-71. doi: 10.1016/j.humpath.2018.04.006. Epub 2018 Apr 22.

PMID:
29684499
24.

Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.

Tardy MP, Di Mauro I, Ebran N, Refae S, Bozec A, Benezery K, Peyrade F, Guigay J, Sudaka-Bahadoran A, Badoual C, Pedeutour F, Saada-Bouzid E.

Oral Oncol. 2018 May;80:104-107. doi: 10.1016/j.oraloncology.2018.04.001. Epub 2018 Apr 7. No abstract available.

PMID:
29631799
25.

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

Lantuejoul S, Adam J, Girard N, Duruisseaux M, Mansuet-Lupo A, Cazes A, Rouquette I, Gibault L, Garcia S, Antoine M, Vignaud JM, Galateau-Sallé F, Sagan C, Badoual C, Penault-Llorca F, Damotte D; pour le groupe pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN). Fondation Synergie Lyon Cancer.

Ann Pathol. 2018 Apr;38(2):110-125. doi: 10.1016/j.annpat.2018.01.007. Epub 2018 Mar 21. French.

PMID:
29571563
26.

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells.

Granier C, Vinatier E, Colin E, Mandavit M, Dariane C, Verkarre V, Biard L, El Zein R, Lesaffre C, Galy-Fauroux I, Roussel H, De Guillebon E, Blanc C, Saldmann A, Badoual C, Gey A, Tartour É.

J Vis Exp. 2018 Feb 8;(132). doi: 10.3791/56606.

PMID:
29553498
27.

Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians.

Outh-Gauer S, Alt M, Le Tourneau C, Augustin J, Broudin C, Gasne C, Denize T, Mirghani H, Fabre E, Ménard M, Scotte F, Tartour E, Badoual C.

Cancer Treat Rev. 2018 Apr;65:54-64. doi: 10.1016/j.ctrv.2018.02.008. Epub 2018 Mar 1. Review.

PMID:
29547766
28.

[Tim-3: a novel biomarker and therapeutic target in oncology].

Granier C, Gey A, Dariane C, Mejean A, Timsit MO, Blanc C, Verkarre V, Radulescu C, Fabre E, Vano Y, Oudard S, Badoual C, Tartour É.

Med Sci (Paris). 2018 Mar;34(3):231-237. doi: 10.1051/medsci/20183403011. Epub 2018 Mar 16. Review. French.

29.

[For 2018, a new editorial board for Annales de Pathologie].

Badoual C.

Ann Pathol. 2018 Feb;38(1):1. doi: 10.1016/j.annpat.2018.01.005. French. No abstract available.

PMID:
29407354
30.

[Papillomavirus, could we speak about cancer and prevention?]

Pernot S, Pavie J, Péré H, Menard M, Hurel S, Cochand-Priollet B, Bats AS, Badoual C.

Bull Cancer. 2018 Feb;105(2):137-139. doi: 10.1016/j.bulcan.2017.12.001. Epub 2018 Jan 17. French. No abstract available.

PMID:
29373106
31.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

Adam J, Le Stang N, Rouquette I, Cazes A, Badoual C, Pinot-Roussel H, Tixier L, Danel C, Damiola F, Damotte D, Penault-Llorca F, Lantuéjoul S.

Ann Oncol. 2018 Apr 1;29(4):953-958. doi: 10.1093/annonc/mdy014.

PMID:
29351573
32.

Exophytic sinonasal papillomas and nasal florid papillomatosis: A retrospective study.

Glâtre R, De Kermadec H, Alsamad IA, Badoual C, Gauthier A, Brugel L, Parra C, Coste A, Prulière-Escabasse V, Bequignon E.

Head Neck. 2018 Apr;40(4):740-746. doi: 10.1002/hed.25042. Epub 2018 Jan 17.

PMID:
29341451
33.

The LXCXE Retinoblastoma Protein-Binding Motif of FOG-2 Regulates Adipogenesis.

Goupille O, Penglong T, Kadri Z, Granger-Locatelli M, Denis R, Luquet S, Badoual C, Fucharoen S, Maouche-Chrétien L, Leboulch P, Chrétien S.

Cell Rep. 2017 Dec 19;21(12):3524-3535. doi: 10.1016/j.celrep.2017.11.098.

34.

Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.

Legras A, Roussel H, Mangiameli G, Arame A, Grand B, Pricopi C, Badia A, Gibault L, Badoual C, Fabre E, Laurent-Puig P, Blons H, Le Pimpec-Barthes F.

Pathol Oncol Res. 2019 Jan;25(1):319-325. doi: 10.1007/s12253-017-0352-x. Epub 2017 Nov 6.

PMID:
29110262
35.

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer.

Granier C, De Guillebon E, Blanc C, Roussel H, Badoual C, Colin E, Saldmann A, Gey A, Oudard S, Tartour E.

ESMO Open. 2017 Jul 3;2(2):e000213. doi: 10.1136/esmoopen-2017-000213. eCollection 2017. Review.

36.

Induction of resident memory T cells enhances the efficacy of cancer vaccine.

Nizard M, Roussel H, Diniz MO, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie JB, Gibault L, Barthes FLP, Granier C, Ferreira LCS, Badoual C, Johannes L, Tartour E.

Nat Commun. 2017 May 24;8:15221. doi: 10.1038/ncomms15221.

37.

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy.

Roussel H, De Guillebon E, Biard L, Mandavit M, Gibault L, Fabre E, Antoine M, Hofman P, Beau-Faller M, Blons H, Danel C, Barthes FLP, Gey A, Granier C, Wislez M, Laurent-Puig P, Oudard S, Bruneval P, Badoual C, Cadranel J, Tartour E.

Oncoimmunology. 2017 Feb 21;6(4):e1286437. doi: 10.1080/2162402X.2017.1286437. eCollection 2017.

38.

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

Pernot S, Badoual C, Terme M, Castan F, Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Bachet JB, Borg C, Ducreux M, Marcheteau E, Stanbury T, Gourgou S, Malka D, Taieb J.

Eur J Cancer. 2017 Jul;79:15-22. doi: 10.1016/j.ejca.2017.03.036. Epub 2017 Apr 26.

PMID:
28456090
39.

Erratum to: Partnering with patients in translational oncology research: ethical approach.

Mamzer MF, Duchange N, Darquy S, Marvanne P, Rambaud C, Marsico G, Cerisey C, Scotté F, Burgun A, Badoual C, Laurent-Puig P, Hervé C.

J Transl Med. 2017 Apr 23;15(1):80. doi: 10.1186/s12967-017-1181-0. No abstract available.

40.

The keys to conservative treatment of early-stage squamous cell carcinoma of the tonsillar region.

Laccourreye O, Castelnau-Marchand P, Rubin F, Badoual C, Halimi P, Giraud P.

Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Sep;134(4):259-264. doi: 10.1016/j.anorl.2017.03.007. Epub 2017 Apr 14. Review.

41.

Partnering with patients in translational oncology research: ethical approach.

Mamzer MF, Duchange N, Darquy S, Marvanne P, Rambaud C, Marsico G, Cerisey C, Scotté F, Burgun A, Badoual C, Laurent-Puig P, Hervé C.

J Transl Med. 2017 Apr 8;15(1):74. doi: 10.1186/s12967-017-1177-9. Erratum in: J Transl Med. 2017 Apr 23;15(1):80.

42.

Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies.

Dariane C, Le Guilchet T, Hurel S, Audenet F, Beaugerie A, Badoual C, Tordjman J, Clément K, Urien S, Pietak M, Fontaine E, Méjean A, Timsit MO.

Urol Oncol. 2017 Feb;35(2):39.e9-39.e17. doi: 10.1016/j.urolonc.2016.09.008. Epub 2016 Oct 27.

PMID:
28341496
43.

Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs.

Stephen-Victor E, Das M, Sharma M, Galeotti C, Fohrer-Ting H, Sendid B, Darnige L, Terris B, Badoual C, Bruneval P, Kaveri SV, Bayry J.

Haematologica. 2017 Jun;102(6):e233-e237. doi: 10.3324/haematol.2016.163451. Epub 2017 Feb 16. No abstract available.

44.

[Quiz: Ready, study, score!]

Roussel H, Gibault L, Verkarre V, Lantuejoul S, Badoual C.

Ann Pathol. 2017 Feb;37(1):7-10. doi: 10.1016/j.annpat.2016.12.014. Epub 2017 Feb 1. French. No abstract available.

PMID:
28161002
45.

[The "immune checkpoints", how does it work].

Granier C, Soumelis V, Mandavit M, Gibault L, Belazzoug R, de Guillebon E, Badoual C, Tartour E, Roussel H.

Ann Pathol. 2017 Feb;37(1):18-28. doi: 10.1016/j.annpat.2016.12.007. Epub 2017 Feb 1. French.

PMID:
28160999
46.

[Predictive biomarkers of efficacy of checkpoint blockade inhibitors in cancer treatment].

Duruisseaux M, Lize-Dufranc C, Badoual C, Bibeau F.

Ann Pathol. 2017 Feb;37(1):46-54. doi: 10.1016/j.annpat.2016.12.016. Epub 2017 Jan 26. Review. French.

PMID:
28131419
47.

[Current events in immunotherapy for upper aerodigestive tract cancer].

Outh-Gauer S, Le Tourneau C, Broudin C, Scotte F, Roussel H, Hans S, Mandavit M, Tartour E, Badoual C.

Ann Pathol. 2017 Feb;37(1):79-89. doi: 10.1016/j.annpat.2016.12.013. Epub 2017 Jan 19. Review. French.

PMID:
28111039
48.

[A special issue dedicated to immuno-oncology].

Bibeau F, Badoual C.

Ann Pathol. 2017 Feb;37(1):1-2. doi: 10.1016/j.annpat.2016.11.004. Epub 2017 Jan 18. French. No abstract available.

PMID:
28109693
49.

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.

Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Pretet JL, Soussan P, Polette M, Lacau Saint Guily J, Birembaut P; Papillophar Study Group.

Br J Cancer. 2017 Jan;116(3):362-369. doi: 10.1038/bjc.2016.434. Epub 2017 Jan 10.

50.

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.

Granier C, Dariane C, Combe P, Verkarre V, Urien S, Badoual C, Roussel H, Mandavit M, Ravel P, Sibony M, Biard L, Radulescu C, Vinatier E, Benhamouda N, Peyromaure M, Oudard S, Méjean A, Timsit MO, Gey A, Tartour E.

Cancer Res. 2017 Mar 1;77(5):1075-1082. doi: 10.1158/0008-5472.CAN-16-0274. Epub 2016 Nov 21.

Supplemental Content

Loading ...
Support Center